Irina Isakova-Sivak (I Isakova-Sivak)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 16

Top Topics

Immune Response

Top Venues

Expert review of vaccines

Human vaccines & immunotherapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Alexandra Ya Rak, Nikolay P Gorbunov, Valeria A Kostevich, Alexey V Sokolov, Polina Prokopenko, Larisa Rudenko, Irina Isakova-Sivak
Assessment of Immunogenic and Antigenic Properties of Recombinant Nucleocapsid Proteins of Five SARS-CoV-2 Variants in a Mouse Model. Viruses 15 (1) (2023)
Alexandra Ya Rak, Nikolay P Gorbunov, Valeria A Kostevich, Alexey V Sokolov, Polina Prokopenko, Larisa Rudenko, Irina Isakova-Sivak
Assessment of Immunogenic and Antigenic Properties of Recombinant Nucleocapsid Proteins of Five SARS-CoV-2 Variants in a Mouse Model. Viruses 15 (1) (2023)
Alexandra Ya Rak, Nikolay P Gorbunov, Valeria A Kostevich, Alexey V Sokolov, Polina Prokopenko, Larisa Rudenko, Irina Isakova-Sivak
Assessment of Immunogenic and Antigenic Properties of Recombinant Nucleocapsid Proteins of Five SARS-CoV-2 Variants in a Mouse Model. Viruses 15 (1) (2023)
Ekaterina Stepanova, Irina Isakova-Sivak, Larisa Rudenko
Options for the development of a bivalent vaccine against SARS-CoV-2 and influenza. Expert review of vaccines 21 (11) (2022)
Irina Isakova-Sivak, Ekaterina Stepanova, Victoria Matyushenko, Sergey A Niskanen, Daria Mezhenskaya, Ekaterina Bazhenova, Elena Krutikova, Tatiana Kotomina, Polina Prokopenko, Bogdan Neterebskii, Aleksandr Doronin, Elena Vinogradova, Kirill S Yakovlev, Konstantin V Sivak, Larisa Rudenko
Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral Vector. Vaccines 10 (7) (2022)
Irina Isakova-Sivak, Elena Grigorieva, Larisa Rudenko
Insights into current clinical research on the immunogenicity of live attenuated influenza vaccines. Expert review of vaccines 19 (1) (2020)
Irina V Kiseleva, Irina Isakova-Sivak, Marina Stukova, Marianna Erofeeva, Svetlana Donina, Natalie Larionova, Elena Krutikova, Ekaterina A Bazhenova, Ekaterina Stepanova, Kirill A Vasilyev, Victoria Matyushenko, Marina Krylova, Julia Galatonova, Aleksey Ershov, Dmitry Lioznov, Erin Grace Sparrow, Guido Torelli, Larisa Rudenko
A Phase 1 Randomized Placebo-Controlled Study to Assess the Safety, Immunogenicity and Genetic Stability of a New Potential Pandemic H7N9 Live Attenuated Influenza Vaccine in Healthy Adults. Vaccines 8 (2) (2020)
Irina Isakova-Sivak, Victoria Matyushenko, Ekaterina Stepanova, Anastasia Matushkina, Tatiana Kotomina, Daria Mezhenskaya, Polina Prokopenko, Igor Kudryavtsev, Pavel Kopeykin, Konstantin Sivak, Larisa Rudenko
Recombinant Live Attenuated Influenza Vaccine Viruses Carrying Conserved T-cell Epitopes of Human Adenoviruses Induce Functional Cytotoxic T-Cell Responses and Protect Mice against Both Infections. Vaccines 8 (2) (2020)
Ekaterina Stepanova, Irina Isakova-Sivak, Larisa Rudenko
Overview of human rhinovirus immunogenic epitopes for rational vaccine design. Expert review of vaccines 18 (9) (2019)
Irina Isakova-Sivak, Victoria Matyushenko, Tatiana Kotomina, Irina V Kiseleva, Elena Krutikova, Svetlana Donina, Andrey Rekstin, Natalia Larionova, Daria Mezhenskaya, Konstantin V Sivak, Arman Muzhikyan, Anastasia Katelnikova, Larisa Rudenko
Sequential Immunization with Universal Live Attenuated Influenza Vaccine Candidates Protects Ferrets against a High-Dose Heterologous Virus Challenge. Vaccines 7 (3) (2019)
Daria Mezhenskaya, Irina Isakova-Sivak, Larisa Rudenko
M2e-based universal influenza vaccines: a historical overview and new approaches to development. Journal of biomedical science 26 (1) (2019)
D Korenkov, T H O Nguyen, Irina Isakova-Sivak, T Smolonogina, L E Brown, K Kedzierska, L Rudenko
Live Attenuated Influenza Vaccines engineered to express the nucleoprotein of a recent isolate stimulate human influenza CD8+ T cells more relevant to current infections. Human vaccines & immunotherapeutics 14 (4) (2018)
Daniil Korenkov, Irina Isakova-Sivak, Larisa Rudenko
Basics of CD8 T-cell immune responses after influenza infection and vaccination with inactivated or live attenuated influenza vaccine. Expert review of vaccines 17 (11) (2018)
Larisa Rudenko, Irina Kiseleva, Elena Krutikova, Ekaterina Stepanova, Irina Isakova-Sivak, Svetlana Donina, Andrey Rekstin, Maria Pisareva, Ekaterina Bazhenova, Tatiana Kotomina, Anastasiia E Katelnikova, Arman Muzhikyan, Valery Makarov, Erin Grace Sparrow, Guido Torelli
Two Live Attenuated Vaccines against Recent Low⁻and Highly Pathogenic H7N9 Influenza Viruses Are Safe and Immunogenic in Ferrets. Vaccines 6 (4) (2018)
Tatiana Kotomina, Daniil Korenkov, Victoria Matyushenko, Polina Prokopenko, Larisa Rudenko, Irina Isakova-Sivak
Live attenuated influenza vaccine viral vector induces functional cytotoxic T-cell immune response against foreign CD8+ T-cell epitopes inserted into NA and NS1 genes using the 2A self-cleavage site. Human vaccines & immunotherapeutics 14 (12) (2018)
Irina Isakova-Sivak, Larisa Rudenko
Tackling a novel lethal virus: a focus on H7N9 vaccine development. Expert review of vaccines 16 (7) (2017)